PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Neurosci. Author manuscript; available in PMC Apr 14, 2010.
Published in final edited form as:
PMCID: PMC2806054
NIHMSID: NIHMS158055

Cytoskeletal Changes Underlie Estrogen’s Acute Effects on Synaptic Transmission and Plasticity

Abstract

Estrogen, in addition to its genomic effects in brain, causes rapid and reversible changes to synaptic operations. We report here that these acute actions are due to selective activation of an actin-signaling cascade normally used in the production of long-term potentiation (LTP). Estrogen, or a selective agonist of the steroid’s beta-receptor, caused a modest increase in fast glutamatergic transmission and a pronounced facilitation of LTP in adult hippocampal slices; both effects were completely eliminated by latrunculin, a toxin that prevents actin filament assembly. Estrogen also increased spine concentrations of filamentous actin and strongly enhanced its polymerization in association with LTP. A search for the origins of these effects showed that estrogen activates the small GTPase RhoA and phosphorylates (inactivates) the actin severing protein cofilin, a downstream target of RhoA. Moreover, an antagonist of RhoA kinase (ROCK) blocked estrogen’s synaptic effects. Estrogen thus emerges as a positive modulator of a RhoA>ROCK>LIM kinase>cofilin pathway that regulates the sub-synaptic cytoskeleton. It does not, however, strongly affect a second LTP-related pathway, involving the GTPases Rac and Cdc42 and their effector p21-activated kinase, which may explain why its acute effects are reversible. Finally, ovariectomy depressed RhoA activity, spine cytoskeletal plasticity, and LTP whereas brief infusions of estrogen rescued plasticity, suggesting that the deficits in plasticity arise from acute, as well as genomic, consequences of hormone loss.

Keywords: theta burst stimulation, hippocampus, spine, Rac/Cdc42, RhoA, ovariectomy

Introduction

Discussions about how estrogen produces strong, positive effects on memory and cognition have largely focused on genomic actions of the steroid. Circulating levels of estrogen influences the number of dendritic spines in certain hippocampal subfields (Gould et al., 1990) and regulates neurotransmitter levels throughout much of the cortical telencephalon (Fink et al., 1996; Lee and Pfaff, 2008). Estrogen also modulates the production of brain growth factors responsible for the maintenance of neuronal processes (Singh et al., 1995; Sohrabji et al., 1995; Pan et al., 1999). Effects of these types, as discussed in the literature, provide reasonable explanations for the link between estrogen and cognition.

Despite the above, recent work suggests that acute, non-transcriptional effects may also contribute to estrogen’s influence over behavior. Short infusions of 17-β-estradiol (hereafter referred to as estradiol or E2), a main form of estrogen, cause small but rapid increases in fast excitatory synaptic responses and markedly facilitate the formation of LTP in hippocampal slices (Foy et al., 1999; Bi et al., 2000; Sharrow et al., 2002; Foy et al., 2008). The plasticity effects are mediated by estradiol beta type receptors (ERβ), which are present in synaptic membranes (Milner et al., 2005), and are accompanied by increased surface expression of AMPA-type glutamate receptors (Liu et al., 2008). These short latency effects on transmission and plasticity are likely related to the acute, non-genomic influence of estradiol on learning (Packard and Teather, 1997; Luine et al., 2003; Rhodes and Frye, 2006) and could therefore underlie variations in memory performance associated with cyclic or age-related changes in E2 production.

Surprisingly little is known about the steps linking estradiol receptors to the complex machinery that regulates synaptic strength. However, work on non-neuronal tissue indicates that the steroid regulates actin dynamics and thereby modifies the sub-membrane cytoskeleton (Giretti et al., 2008). This is of potential relevance to its acute actions in adult brain because rapid, activity-driven changes to the spine cytoskeleton play an essential role in the production of LTP (Lynch et al., 2007; Messaoudi et al., 2007). Questions thus arise as to whether estradiol acutely regulates the cytoskeleton at adult synapses and if such effects are responsible for its actions on baseline transmission, plasticity, and learning. Moreover, a short latency connection to actin networks would help explain why natural fluctuations in estradiol levels, or acute injections of the steroid, are accompanied by changes in spine morphology and number.

Here we report that estradiol produces its acute synaptic actions by selectively stimulating one of the multiple actin signalling cascades involved in the production of stable LTP. We also found that ovariectomy depresses the same pathway, suggesting that the loss of plasticity associated with this chronic manipulation (Singh et al., 1994; Fink et al., 1996; Smith and McMahon, 2005, 2006; Liu et al., 2008) arises from the continuing absence of estradiol’s acute effects on synapses. Initial tests of this idea proved positive. The linkages between estradiol receptors and the spine cytoskeleton described here may thus have significance for ideas about the origins of, and potential treatments for, memory problems that can accompany surgical ovariectomy or menopause.

Methods

All animal procedures were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and with protocols approved by the Institutional Animal Care and Use Committee of the University of California at Irvine. This includes efforts to minimize animal suffering and numbers of rats used in the work described.

Slice preparation and recording

Studies employed young adult (30–42 day old) male Sprague-Dawley rats (Charles River, Wilmington, MA) and middle-aged (retired breeders at 9–10 mo old) ovariectomized (OVX) Long Evans rats (Charles River, Wilmington, MA). Methods were slightly modified from those described previously (Kramár et al., 2006). Briefly, acute hippocampal slices were prepared and maintained in an interface recording chamber containing preheated artificial cerebrospinal fluid (aCSF) of the following composition (in mM): 124 NaCl, 3 KCl, 1.25 KH2PO4, 1.5 MgSO4, 2.5 CaCl2, 26 NaHCO3, and 10 glucose and maintained at 31 ± 1°C. Slices were continuously perfused with this solution at a rate of 1.75–2 ml/min while the surface of the slices were exposed to warm, humidified 95% O2/5% CO2. Recordings began following at least 1.5 hr of incubation.

Field excitatory postsynaptic potentials (fEPSPs) were recorded from CA1b stratum radiatum using a single glass pipette (2–3 MΩ). Stimulation electrodes (twisted nichrome wires, 65 μm) were positioned at two sites (CA1a and CA1c) in the apical Schaffer collateral-commissural projections to provide convergent activation of CA1b pyramidal cells. Pulses were administered in an alternating fashion to the two electrodes at 0.05 Hz using a current that elicited a 50% maximal response. After establishing a 10–20 min stable baseline, test compounds (see below) were introduced into the infusion line by switching from control aCSF to drug-containing aCSF. To determine the LTP threshold and ceiling effect in control and drug-treated slices, the number of ‘theta’ bursts delivered to induce LTP varied from 2 to 10, with each burst consisting of four pulses at 100 Hz and the bursts themselves separated by 200 msec (i.e., theta burst stimulation or TBS). The stimulation intensity was not increased during TBS. Data were collected and digitized by NAC 2.0 Neurodata Acquisition System (Theta Burst Corp., Irvine, CA) and stored on a disk.

Reagents

WAY20070 and 4,4′,4″-[4-propyl-(1H)-pyrazole-1,3,5-triyl]trisphenol (PPT) were provided by Wyeth Pharmaceuticals (Monmouth, NJ). H-1152P dihydrochloride (Tocris, Ellisville, MO), D-(−)APV (Tocris), DNQX (Tocris), picrotoxin (Sigma, St. Louis, MO) and saclofen (Tocris) were prepared fresh in aCSF, while PPT, WAY20070, 17-β estradiol, ICI-182,780 (Tocris), and latrunculin A (EMD Chemicals, San Diego, CA) were dissolved in DMSO and diluted to working concentrations in aCSF (DMSO <0.01%, final).

In situ phalloidin labeling

Methods were slightly modified from those described previously (Kramár et al., 2006). Rhodamine- (Sigma) or Alexa568 (Invitrogen, Carlsbad, CA)-phalloidin (6μM) was applied topically from a micropipette every 5 min for 20 min either (1) at the end of the experiment in slices that received low-frequency stimulation in the presence or absence of drugs or (2) 10 to 60 min after the delivery of theta bursts. Slices were then collected and prepared for microscopy. Labelling was examined using a Zeiss Axioscop microscope (40X, Apochromat, NA 1.2) and an Axiocam camera. Identification and measurement of labelled spines was performed on a 35,700 μm2 sampling area within the zone of physiological recording as described (Lin et al., 2005; Kramár et al., 2006; Rex et al., 2007). To quantify the total number of labelled spines, a fixed-interval intensity threshold series (15–75% of maximum, spaced by 4%) was used to detect boundaries of both faintly and densely labelled spines under conditions of drug application during low-frequency stimulation. Redundant observations from the threshold series were analyzed using Matlab (Mathworks) to produce a best boundary estimate for each spine. Spine intensity was calculated as mean pixel intensity for all pixels assigned to a given spine. In slices receiving TBS, analysis by single threshold was set at 75% of maximum image intensity to detect only densely labelled spines.

Chronic estradiol treatment

Long Evans rats at middle-age (9–10 mo old) were ovariectomized and 6 months later randomly divided into two groups: One group received estradiol replacement therapy (control group) and the other remained estradiol-depleted (experimental group). For hormone replacement the estradiol analog 17-β estradiol benzoate (EB), maintained in a stock solution of 10μg/0.1ml in sesame oil, was injected subcutaneously once per day, every other day, for 2 weeks (Woolley and McEwen, 1993). Experimental animals received similar injections of sesame oil. At 24 h after the last injection rats were decapitated, one side of the hippocampus was used for slice physiology experiments and the other was frozen and used to measure activated RhoA (see below). To verify the ovariectomy and sufficiency of EB replacement, the uterus was severed from the cervix, cleared of fat from the uterine tubes, and blotted dry on tissue paper to remove luminal fluid before being weighed. Uteri from EB-injected animals weighed, on average (±SEM), twice as much as uteri collected from vehicle-injected rats and were highly vascularized and filled with fluid (uterine weight: 0.185 ± 0.02g, and 0.373 ± 0.02g for vehicle- and EB-treated rats, respectively; n=8/group).

Western Blot analysis

Hippocampal slices were pooled (2–3/group), homogenized in radioimmunoprecipitation assay buffer containing Phosphatase Inhibitor Cocktails 1 and 2 and Complete Protease Inhibitor Cocktail (Roche Diagnostics, Palo Alto, CA) (Rex et al., 2007), normalized for protein content (Bio-Rad Protein Assay), separated by 12% SDS-PAGE and processed for Western blot analysis using rabbit antisera to pPAK1/2/3 (44-940G; S141, Biosource, Carlsbad, CA) and pCofilin (112866; S3, Abcam, Cambridge, MA) and the ECL Plus chemiluminescent detection system (Amersham, Piscataway, NJ). Blots were re-blotted (Millipore, Temecula, CA) and probed for β-tubulin and β-actin (Sigma) as loading controls. ImageJ (NIH) software was used to measure the intensity of immunoreactive bands. Statistical significance was determined by two-tailed student’s t-test. N values are presented as number of samples tested.

Pulldown assays for activated Rho GTPases

Samples (6–10 slices pooled) were homogenized in 1X Mg2+ Lysis Buffer (MLB) (Millipore) with Complete Protease Inhibitor Cocktail (Roche Diagnostics) and 10% glycerol. Protein levels were measured and normalized. Samples were incubated with Rac/Cdc42 (PAK-1 PBD; 14-325, Millipore) or RhoA (Rhotekin RBD; 14-383, Millipore) Assay Reagent and gently rocked for 4 h at 4°C. Substrate rhotekin binds strongly to both RhoA and RhoC, but weakly to RhoB (Reid et al., 1996). RhoC is not present in brain, thus RhoA was specifically detected in blots probed with the RhoA antibody. Agarose beads were collected by centrifugation (10 sec, 14,000g, 4°C) and washed 3 times with MLB, resuspended and boiled in Laemmli buffer, and then separated by SDS-PAGE. Western blot analysis was performed using mouse anti-RhoA (418; Santa Cruz), mouse anti-Rac (05-389; Millipore), or rabbit anti-Cdc42 (4201; Millipore). For GTP and GDP loading controls, samples were incubated with 100μM GTPγS or 1mM GDP (30 min at 30°C with agitation) before assay with reagents.

Data analysis

All electrophysiological measures are presented in the text as mean ± S.D. and in figures as mean ± S.E.M. Data were collected from control slices in parallel with experimental tissue for each treatment tested. The sample size for all experiments represents the number of animals used unless otherwise noted. At the end of each experiment, measurements from control slices were pooled and used as the comparison to drug-treated slices. Student’s t-tests, using p<0.05 significance criteria (two-tailed), were used to compare groups for electrophysiology, Western blot analyses and measures of spine labelling. Analysis of mean spine labelling intensity used the non-parametric Kruskal-Wallis one-way analysis of variance by ranks test. Pairwise comparisons were evaluated post-hoc using the method of Bonferroni. The alpha level of these comparisons was set at p<0.01, following a Round Robin-style assessment of variance between repeated trials (>100) of the Kruskal-Wallis test with control group data.

Results

Estradiol increases synaptic responses via an action on AMPA receptors

In agreement with earlier reports (Foy et al., 1999; Bi et al., 2000; Sharrow et al., 2002; Foy et al., 2008), infusion of 1nM estradiol (E2) caused a rapid increase in the synaptic response elicited by stimulation of the Schaffer-commissural projections to field CA1b stratum (str.) radiatum. The effect, which began within 5–10 minutes after the start of infusion and reversed completely during washout, was highly reproducible and consisted of a 17% ± 3 increase over baseline by 20 min after the start of infusion. The magnitude of the increase was comparable to that reported by other groups. The threshold for the E2-induced changes in baseline transmission fell between 0.01nM (−1 ± 0.3%) and 0.1nM (+6 ± 1.6%) (Fig 1A). The changes to the fEPSP slope produced by 0.1 and 1.0nM E2 were significantly different than those obtained with 0.01nM E2 (p<0.05, ANOVA with post-hoc tests). Comparable results were obtained with a 20 min infusion of WAY200070 (WAY), a selective agonist of ER-s: 10 and 100nM treatments increased fEPSP slopes by 5 ± 2% and 17 ± 4% respectively, while 1nM had no detectable effect (Fig 1B). PPT, an agonist for estradiol receptor alpha (ER-α), at 100nM did not reliably affect synaptic responses (+1 ± 1%). The differences between groups infused with WAY and PPT were highly significant (p<0.001, ANOVA: F=56.09) and the increases found with WAY at 10nM and 100nM were reliably larger in post-hoc tests than those obtained with 1nM WAY or PPT.

Figure 1
Estrogen receptor stimulation reversibly increases synaptic transmission

The enhanced responses in the presence of 1nM E2 and 100nM WAY were not accompanied by changes in paired-pulse facilitation (p ≥ 0.5 at all intervals tested), and so are not likely due to changes in transmitter release kinetics (Fig 1C). They were also selective to glutamate receptors because E2 did not affect the size of the ‘field inhibitory postsynaptic potential’ (fIPSP), a picrotoxin-sensitive response recorded in the presence of AMPA and NMDA receptor antagonists. Specifically, the amplitude of the fIPSP recorded 30 min after infusing 1nM E2 was within 1 ± 11% of the pre-hormone baseline (Fig 2A). We also tested if E2 affects the presynaptic GABA-B auto-receptors that shape transmitter release from feedforward GABAergic interneurons with repetitive stimulation (Arai et al., 1995). As shown in Figure 2A, the fIPSP generated by the second of two stimulation pulses under baseline conditions (aCSF) is reduced relative to the first response when the pulses are separated by 200 msec. The paired-pulse depression effect during baseline (−47 ± 11%), which is significantly reduced by the GABA-B receptor antagonist saclofen (−36 ± 6.8%, p < 0.002), was unaffected by infusions of 1nM E2 (−46 ± 6%; aCSF vs E2, p=0.38).

Figure 2
Estradiol selectively facilitates AMPA receptor-mediated components of fast EPSPs

By exclusion, the above results point to ionotropic glutamate receptors as the likely sites at which E2 acts to increase transmission. Given their pre-eminent role in mediating fast EPSPs, AMPA receptors emerge as the probable targets. This does not rule out the possibility that the steroid also impacts the NMDA receptors, something that would be of great importance to an analysis of how it influences LTP. Accordingly, we pharmacologically isolated the NMDA receptor-mediated component of the synaptic response by infusing DNQX (20μM) and picrotoxin (100μM) to block AMPA and GABA-A receptor mediated response components, and then tested for possible effects of E2. Infusions that reliably enhanced fEPSPs in untreated slices did not measurably change the amplitude of the NMDA receptor-dependent fEPSP 20 min after the start of infusion (aCSF = +1 ± 2.5% vs 1nM E2 = −1 ± 1.1%, p>0.60) (Fig 2B). This result, in addition to ruling out an action on NMDA receptors, reinforces the conclusion that E2 does not enhance release or cause generalized changes to the post-synaptic environment. Finally, we confirmed, as expected from the above, that pharmacologically isolated AMPA receptor-mediated fEPSPs (NMDA and GABA-A receptors blocked) are positively modulated by 1nM E2 (Fig 2C).

Estradiol lowers the threshold and raises the ceiling for LTP

We tested for LTP in the presence of E2 after adjusting the stimulation pulse strength to produce responses equivalent in size to those recorded during the pre-infusion baseline. Past studies have shown that estradiol enhances the potentiation effect (Foy et al., 1999; Bi et al., 2000; Foy et al., 2008); we were interested in whether this reflects a reduction in the LTP threshold or an elevation of its normally present ceiling, two variables that are diagnostic with regard to mechanisms. A single pair of theta bursts did not produce stable potentiation in vehicle-treated slices (30 min after induction = +2 ± 4%), but did cause potentiation (+23 ± 3%) in slices infused with 1nM E2. The delivery of three bursts had small, variable effects in control slices (+14 ± 6%) but generated robust LTP when delivered in the presence of 1nM E2 (+44 ± 5%). Five theta bursts produced stable potentiation in the controls (+27 ± 2%) and a supra-normal amount of potentiation in slices infused with E2 (+63 ± 6%). Slices perfused with 100nM WAY reproduced the pattern of results obtained with E2 (2 bursts = +20 ± 4%, 3 bursts = +33 ± 5%, 5 burst = +73 ± 11%), while responses in slices infused with the ER-α agonist PPT (2 bursts = +2 ± 2%, 3 bursts = +10 ± 3%, 5 bursts = +30 ± 9%) were comparable to controls (Fig 3A). Past studies have shown that TBS trains with more than 10 bursts, or with spaced administration of multiple 10 burst trains, do not generate greater responses than are obtained with a single train (Larson et al., 1986; Kramár et al., 2004); both E2 (+80 ± 15%) and WAY (+109 ± 26%) nearly doubled the amount of potentiation normally obtained with a conventional 10-burst train (Veh: +45 ± 6%; PPT: +50 ± 18%). Slices infused with E2 or WAY had significantly greater LTP at 30 min post-TBS than control or PPT-treated cases (F = 30.5, p <0.001). Thus, E2 both lowers the threshold and raises the ceiling for LTP induced by naturalistic patterns of afferent stimulation.

Figure 3
Effects of estrogen receptor stimulation on the threshold and ceiling for LTP in field CA1

In an effort to determine if the steroid acts on the synaptic events used to induce LTP, we measured the extent to which the burst responses facilitated over the course of a theta train. There were no evident differences between control slices and those treated with estradiol, or the estrogen receptor agonists, on this measure (p = 0.22, one-way ANOVA) (Fig 3B). The magnitude of the NMDA receptor-mediated component of the burst responses was assessed by comparing the size of the second of the responses to a pair of theta bursts in the presence and absence of the selective NMDA receptor antagonist APV. The NMDA receptor contribution to burst size was the same in control (+37 ± 6%) and 1nM E2-treated slices (+35 ± 4%; p > 0.8) (Fig 3C). We conclude from this set of results that acute estradiol exerts its effects at a stage following the triggering events for LTP.

Acute synaptic effects of estradiol involve actin polymerization within dendritic spines

Infusions of ICI-182,780 (100μM), which blocks binding to estradiol’s nuclear receptors, did not alter baseline synaptic transmission or affect the rapid increases in fEPSP responses induced by 1nM E2 (Fig 4A). The response facilitation produced by E2 in the presence of ICI-182,780 (+14± 3%) was comparable to that obtained in multiple experiments (e.g., Fig 1) without the inhibitor (+17 ± 3%; p>0.3).

Figure 4
Latrunculin blocks the effects of estradiol on synaptic physiology

We then used latrunculin, a toxin that blocks the addition of actin monomers to growing filaments, to test if actin polymerization plays a role. The compound had no measurable influence on baseline fEPSP slope, in accord with previous reports (Krucker et al., 2000; Rex et al., 2007), but eliminated the effects of E2 on fEPSPs (Fig 4B). E2 also failed to promote LTP in latrunculin-treated slices: Attempts to induce potentiation in the experimental pathway resulted in a robust short-term potentiation that gradually decayed back to baseline (60 min post-TBS = +4 ± 5% vs baseline). These results confirm that facilitation of LTP by E2 is thoroughly dependent upon the same actin assembly processes that operate in the absence of the steroid.

Latrunculin by itself did not alter the amplitude of the isolated NMDA receptor response (baseline = 0.22± 0.03mV vs. 60 min infusion of latrunculin = 0.22 ± 0.03 mV), the composite response (4 overlapping EPSPs) to a single theta burst (areas of burst response 54 ± 11 mV. msec for vehicle-treated slices and 45 ± 8 mV.msec for the latrunculin cases; p=0.15), or the NMDA receptor-mediated component of burst size (Veh = 33.0 ± 8.9% vs. latrunculin = 33.7 ± 11.6% of the total response area). The facilitation of burst responses that occurs within a train was similarly unaffected by the toxin (% facilitation of area from burst 1 to burst 5 was 88 ± 42% and 66 ± 22% for vehicle vs. latrunculin slices; p>0.3). Theta burst responses and their enhancement are markedly affected by manipulations acting on frequency facilitation of transmitter release, NMDA receptors, GABA receptors, and after-hyperpolarizing potentials (Larson et al., 1986; Arai and Lynch, 1992; Sah and Bekkers, 1996). The failure of latrunculin to change burst responses or short-term potentiation thus constitutes strong evidence that acute administration of the toxin does not significantly influence the complex machinery that regulates the magnitude of synaptic responses. More extended treatments, however, would be expected to disrupt ongoing filament assembly/disassembly processes underlying the maintenance of cell junctions including synapses.

E2 produced its normal increase in synaptic responses in both control and experimental pathways when applied after a 90 min washout of latrunculin (control path = +14 ± 4% and experimental path = +20 ± 8%) (Fig 3B). WAY-induced increases in fEPSPs were also thoroughly and reversibly blocked by latrunculin (latrunculin + WAY = −6 ± 6%; WAY alone = +16 ± 7%, p<0.001) (Fig 4C).

The above results suggest that E2 triggers actin filament assembly in the sub-synaptic region. Direct tests of this were carried out by applying fluorescence-tagged phalloidin, a toxin that selectively binds to filamentous (F-) actin, to slices following a 20 min infusion of E2. The slices were fixed, sectioned, and examined with epifluorescence microscopy. Field CA1 str. radiatum contained a sparse population of small, densely fluorescent structures in slices receiving low frequency stimulation (LFS) in the absence of estrogen (Fig 5A, left panel); previous work indicates that these profiles correspond to labelled dendritic spines (Lin et al., 2005; Kramár et al., 2006; Rex et al., 2007). It appeared from survey micrographs that E2 increased the number of phalloidin-positive spines throughout field CA1 (Fig 5A, top right). This effect was altogether absent in E2 slices that had been pre-treated for 30 min with latrunculin (Fig 5A, bottom right). Blind quantitative analyses using an automated system (see Methods) confirmed that slices receiving a 20 min infusion of E2 had a greater number of spines containing high concentrations of F-actin than did yoked control slices (p = 0.0005; Fig 5B). Further analysis of all (light to dense) labelled spines showed that the frequency distribution of labelling intensities was shifted in a latrunculin-sensitive manner towards higher values (Kruskal-Wallis, Χ2=343.75, P< 0.001) (Fig 5C). This is as expected if E2 acts uniformly to increase F-actin in a population in which individual elements (spines) differed significantly with regard to starting concentrations of F-actin.

Figure 5
Estradiol promotes actin polymerization in dendritic spines

If estradiol by itself causes a modest increase in actin filaments in spine heads, then it could potentially augment the theta-burst induced polymerization needed for stable LTP. Tests of this were carried out using a TBS train that was sub-threshold for eliciting a reliable increase in the number of spines containing high concentrations of F-actin. Three theta bursts produced a pronounced short-term potentiation that rapidly decayed back to baseline in vehicle-treated slices (Fig 6A). Slices collected 60 min post-TBS had about the same number of phalloidin-labelled spines within the target dendritic lamina as did control (no TBS) slices (Fig 6B,C). A 20 min infusion of E2 caused the expected increase in fEPSPs that decayed over a 60 min wash-out (Fig 6A); these slices, collected at the end of the washout, had the same number of densely labelled spines as untreated slices (Fig 6B,C). This result establishes the point that the E2-driven actin polymerization described in figure 5 is fully reversible. The three-burst theta train that failed to produce stable LTP under control conditions caused a robust, non-decremental potentiation effect when administered at the end of a 20 min E2 infusion (Fig 6A). It also produced a lasting increase in phalloidin-labelled spines as seen in slices collected after a 60 min washout of E2 and, accordingly, 60 min post-TBS (Fig 6B,C). In all, a brief exposure to E2 markedly enhances the effects of TBS on both actin polymerization and LTP.

Figure 6
E2 enhances theta burst-induced LTP and actin polymerization

Estradiol selectively facilitates a signalling pathway that controls actin polymerization

How does E2 promote actin polymerization in dendritic spines? We investigated this beginning with cofilin, a constitutively active protein that severs dynamic actin polymers. Phosphorylation inactivates cofilin and accordingly clears the way for the elongation, branching, and stabilization of filaments. Western blot assays showed that E2, infused for 20 min as in the electrophysiology experiments, caused an approximately 50% increase in the concentration of phosphorylated (p)-cofilin (n=6/group; p=0.04); total cofilin levels were unaffected by the steroid (Fig 7A).

Figure 7
Estradiol selectively activates a RhoA to actin signaling pathway

LIM Kinases (LIMK), the primary up-stream regulators of cofilin, are targets of two signalling cascades initiated by Rho family GTPases: (a) Rac/Cdc42 [dbl greater-than sign] p21-activated kinase (PAK) and (b) RhoA [dbl greater-than sign] RhoA kinase (ROCK) (Edwards et al., 1999; Maekawa et al., 1999). We used pull down assays to test if either of these pathways is used by E2 and found that the steroid causes a profound increase in activated (GTP-bound) RhoA (n=5/group; p=0.04) with little if any change in Rac and Cdc42 activity (n=3–5/group; p=0.08) (Fig 7B). The E2-induced increase in RhoA activity returned to control levels following a 60 min washout; this supports the hypothesis that acute applications of E2 cause transient and reversible forms of plasticity. Total concentrations of the GTPases (active and inactive) were not affected by 1nM E2. In agreement with its lack of effect on Rac/Cdc42, E2 caused a small decrease in the phosphorylation (activation) of PAK, a primary effector for these two GTPases (n=8/group; p=0.008) (Fig 7C).

Collectively, the results just described point to the conclusion that E2 phosphorylates cofilin by activating RhoA- rather than Rac/Cdc42-initiated signalling. If RhoA initiates the pathway primarily responsible for E2’s effects on synaptic physiology, then selective inhibitors of RhoA’s effector ROCK should block E2-induced changes in fEPSPs. In accord with this, 30min pretreatment of hippocampal slices with the selective ROCK inhibitor H1152P (Sasaki et al., 2002), at concentrations (250nM) shown in other studies to block TBS-induced phosphorylation of cofilin (Rex et al., 2009) eliminated E2’s effects on fEPSPs (Fig 7D). A 20 min infusion of H1152P alone did not alter baseline fEPSP slope (+1 ± 2%) but completely blocked E2-induced increases in synaptic transmission (−2 ± 3%). Following a 60 min washout period, reintroduction of 1nM E2 alone caused significant increases in fEPSP slope (+17 ± 2%, p=0.003 vs. E2 + H1152P) that returned to baseline during washout.

Actin signalling after prolonged loss of estradiol

Finally, the question arises as to whether effects of the type described above contribute to the behavioral changes associated with extended periods of low estradiol. We explored this using long-term (6 month) ovariectomized rats given estrogen replacement (OVX + EB) or vehicle injections (OVX + Veh) for two weeks prior to testing. Input/output curves (Fig 8A) and paired-pulse facilitation (Fig 8B) were comparable for the two groups, and not noticeably different from results collected from young adult rats (see Fig. 1C). However, LTP (fEPSP slope 60 min post-TBS = +17 ± 15%) was clearly impaired in the OVX + Veh slices relative to what is found at the same set of synapses in young adult or middle-aged male rats (Fig 8C) (Rex et al., 2005). OVX rats given estrogen replacement for 2 weeks prior to slice preparation expressed normal appearing LTP (fEPSP slope 60 min post-TBS = +54 ± 10%; p < 0.0001 vs. OVX + Veh), as previously reported for mice (Gureviciene et al., 2003) and for short-term OVX rat models (Smith and McMahon, 2005, 2006). The cause of the impairment in the OVX + Veh group appears to reside in the processes underlying the stabilization, as opposed to the induction and expression, of LTP. The size (area) of the four EPSP responses to a single theta burst was not detectably different in slices from OVX + EB vs. OVX + Veh rats (not shown). The burst facilitation that occurs within the train was also comparable for the two groups: The mean percent enhancement in area for bursts 2–10 relative to the first burst was 30 ± 16% and 33 ± 20% in slices from OVX rats with and without EB replacement, respectively (Fig 8D). Beyond this, LTP expression for the first two minutes post-TBS was 84 ± 45% above baseline in slices prepared from OVX + Veh and 94 ± 17% from OVX + EB rats (p>0.5). However, despite this initial robust potentiation, LTP decayed rapidly and failed to establish a stable plateau in the slices from vehicle-injected OVX rats.

Figure 8
Ovariectomy disrupts actin signaling and synaptic plasticity in CA1

Since actin dynamics play a central role in LTP stabilization, (Okamoto et al., 2004; Kramár et al., 2006; Chen et al., 2007; Rex et al., 2007) we used the in situ phalloidin labelling technique to test for changes in TBS-induced actin polymerization. A high detection threshold was used so that the results could be directly compared with those from prior work on slices from young adult rats (Lin et al., 2005; Kramár et al., 2006). The two groups of OVX slices (with and without prior EB replacement) had the same number of labelled spines under low-frequency stimulation conditions but differed markedly in their responses to TBS. A 10-burst train produced an ~11-fold increase in the number of densely labeled spines in slices from OVX + EB rats (Fig 8E,F); this value is comparable to the 10–14 fold effects reported for slices from 2–3 month old male rats (Lin et al., 2005; Kramár et al., 2006). A substantially smaller increase (<5-fold) was obtained in slices from the OVX + Veh group; the difference between the two OVX groups was highly significant (p=0.0007; n=8 slices/group).

It appears that chronic reduction of E2 depresses one or more steps in the sequences driving actin filament assembly in spines. Given that E2 causes a substantial increase in RhoA activity (see Fig. 6A), we asked if baseline levels of the small GTPase differ between OVX rats with and without hormone replacement. Pull down assays showed that concentrations of GTP-bound RhoA were substantially lower in hippocampal homogenates prepared from OVX + Veh vs. OVX+EB rats (n=4/group; p=0.02)(Fig 8G).

The above findings raise the broad and therapeutically important question of whether ovariectomy, without hormone replacement, blocks the acute effects of E2 on actin signalling and synaptic plasticity. Experiments directed at this issue showed that a 30 min infusion of 1nM E2 produces the same rapid and modest increase in baseline synaptic responses (13 ± 4%, p < 0.001 vs baseline) in slices from OVX + Veh rats as in slices from young adult male rats (Fig 9A). Acute infusions of E2 also significantly increased numbers of spines with dense concentrations of F-actin (p=0.008 vs controls), caused a significant rightward shift in the phalloidin-label intensity frequency distribution (p<0.001) (Fig 9B–D) and rescued TBS-driven increases in actin polymerization (not shown). As anticipated from these effects, 20 min pre-treatment with the steroid fully restored stable LTP in slices prepared from middle-aged, OVX rats (60 min post-TBS: +49 ± 12% vs. +19 ±8% for untreated slices; p=0.002) (Fig 9E).

Figure 9
Acute infusions of estradiol offset the effects of ovariectomy on actin dynamics and synaptic plasticity

Discussion

The acute effects of estradiol on LTP and memory encoding have important implications for arguments about why cognitive performance fluctuates with the estrous cycle and declines with age (Markowska, 1999). They are also suggestive of therapeutic applications, particularly in light of evidence that highly selective agonists for ER-β enhance plasticity and memory in the absence of many of estradiol’s peripheral actions (Liu et al., 2008). Further progress in these areas will require information about how estradiol produces its rapid actions. The present results point to a specific conclusion regarding this question; namely, that estradiol affects synaptic physiology by partially activating one, but not all, of the actin signalling pathways used in the generation of stable LTP. The hormone thus produces a weak and transient form of LTP; this has the effect of modestly increasing baseline responses and markedly enhancing the LTP produced by theta activity.

The first suggestion of a previously unsuspected influence of estradiol on actin dynamics came with the observation that latrunculin, a selective toxin that blocks the addition of actin monomers to growing filaments, eliminated the hormone’s influence on baseline synaptic responses. We then found, as anticipated from the latrunculin results, that estradiol caused a modest but reliable increase in spine concentrations of filamentous actin. Also in agreement with the idea that estradiol acts on LTP-related actin signalling pathways, it markedly amplified theta burst-induced actin polymerization in spines. Given the now extensive evidence that actin polymerization is essential for the formation of stable LTP (Krucker et al., 2000; Fukazawa et al., 2003; Okamoto et al., 2004; Kramár et al., 2006; Rex et al., 2007; Rex et al., 2009), the observed interaction between estradiol and TBS provides a likely explanation for why the steroid so potently enhances the potentiation effect. A selective agonist of ER-β produced effects comparable to those obtained with estradiol and these were also blocked by latrunculin.

An analysis of the signalling cascades upstream from actin provided further support for estradiol’s links to the substrates of LTP. Theta bursts cause a rapid but transient (~15 min) increase in cofilin phosphorylation (Chen et al., 2007) and we found that estradiol produces a similar effect. Cofilin is a constitutively active, actin severing protein; phosphorylation inactivates cofilin and facilitates actin filament assembly (Gungabissoon and Bamburg, 2003; Thirone et al., 2009). Estradiol therefore promotes changes in actin management that enable actin polymerization and support the production of LTP. However, while the steroid engages certain actin-related effects that follow LTP induction, it leaves others relatively unaffected. In addition to driving cofilin phosphorylation, theta bursts cause a rapid and transient increase in the number of synapses in the activated dendritic zone that are associated with dense concentrations of phosphorylated (activated) PAK. It was originally thought that this PAK response to TBS leads to increases in cofilin phosphorylation via PAK>LIMK>cofilin signalling (Chen et al., 2007) but recent results have called this idea into question. Specifically, adenosine, a negative modulator of LTP, blocks TBS-induced cofilin phosphorylation and actin polymerization without depressing TBS effects on PAK phosphorylation (Rex et al., 2009). Estradiol, which promotes LTP, produces an inverse pattern of results in that it facilitates cofilin phosphorylation and actin assembly while mildly depressing PAK activation. The steroid did not measurably affect baseline activation of PAK’s upstream regulators Rac/Cdc42 (Fig 7), so its effect on p-PAK could reflect an action on the multiple protein phosphatases that target the kinase (Zhan et al., 2003).

How, then, do theta bursts and estradiol inactivate cofilin? Beyond its involvement in the Rac/Cdc42 > PAK > LIMK cascade, there is substantial evidence that LIMK is also a target for RhoA’s effector ROCK (Maekawa et al., 1999; Ohashi et al., 2000; Thirone et al., 2009). Our results indicate that the latter pathway (i.e., RhoA > ROCK > LIMK>cofilin) is used by estradiol to modulate actin polymerization and synaptic physiology. The hormone activated RhoA while its actions on synaptic responses were completely blocked by a selective inhibitor of ROCK. This again links E2 to an LTP pathway because ROCK inhibitors completely disrupt consolidation of the potentiation effect (Rex et al., 2009).

The above results raise questions about the functional consequences of estradiol’s failure to initiate the cascades involving Rac/Cdc42 > PAK signalling. Possibly related to this, multiple experiments have shown that the actin filaments that quickly form after TBS are, like LTP itself, unstable for a period of several minutes and then become resistant to disruption (Krucker et al., 2000; Kramár et al., 2006; Rex et al., 2007; Rex et al., 2009). Recent work showed that selective inhibitors of Rac or PAK have no effect on either TBS-induced actin polymerization, but block the stabilization of both the newly formed filaments and LTP that normally occurs in the 15 minutes following TBS (Rex et al., 2009). These observations help explain why estradiol’s acute effects reverse so readily; that is, the failure of the steroid to engage Rac/Cdc42 > PAK signalling could mean that the actin networks it causes to assemble remain dynamic and inherently unstable. In accord with this, we found that a 60 min wash-out eliminates the increase in phalloidin labelling of F-actin produced by E2.

The idea that estradiol-induced increases in synaptic responses represent a type of weak and transient LTP necessarily predicts that the hormone’s actions on the cytoskeleton ultimately activate the same synaptic processes that express the potentiation effect. It is now generally agreed that these latter events involve expansion of the pool of AMPA-type glutamate receptors that mediate fast EPSPs in hippocampus (Newpher and Ehlers, 2008). Consonant with this is recent evidence that TBS-induced phosphorylation of synaptic cofilin is associated with substantially enlarged post-synaptic densities (PSDs) (Chen et al., 2007) and therefore with a greater territory for docking AMPA receptors (Matsuzaki et al., 2004; Okamoto et al., 2004). Comparable studies have not been conducted after acute estradiol treatment but it is known that estradiol increases surface expression of the GluR1 subunit of the AMPA receptor (Liu et al., 2008). It will be of considerable interest to test if the hormone causes a modest enlargement of PSDs (commensurate with its influence on EPSPs) and if this effect, along with estradiol’s actions on AMPA receptor surface expression, requires actin filament assembly.

The actions of estradiol on the spine cytoskeleton, as described here, also provide a plausible explanation for fluctuations in spine numbers and LTP in hippocampus across phases of the estrous cycle (Woolley et al., 1990; Warren et al., 1995). Spine growth and retraction in dissociated neurons are driven by changes in the underlying cytoskeleton (Honkura et al., 2008) while the production of LTP, as noted, depends on actin filament assembly and stabilization. Baseline concentrations of F-actin vary considerably across spines (see fig 5C) and it is conceivable that some cytoskeletal configurations are more dependent upon estradiol than others. In any event, an across days analysis of spine pCofilin and F-actin concentrations would constitute a first step in determining whether the mechanisms described here are involved in spine changes associated with the different stages of the estrous cycle.

Finally, and of considerable clinical significance, is the issue of whether the absence of estradiol’s short-latency actions on the cytoskeleton and plasticity are important contributors to behavioral changes arising from surgical ovariectomy or menopause. We found that RhoA activity, a key element in the path leading to stable LTP, was significantly depressed in OVX rats relative to the levels recorded for hormone replacement animals. Moreover, spine levels of activated LIM Kinase, a target of RhoA and a key upstream regulator of cofilin, are depressed in OVX rats without hormone replacement (Yildirim et al., 2008). Baseline activity levels of the small GTPases are not reliably reflected in downstream effectors (Thaxton et al., 2007; Rex et al., 2009) but depressed levels of RhoA would place the OVX hippocampus at a disadvantage with regard to activity-driven cytoskeletal reorganization and, indeed, we found major deficits in TBS-induced actin polymerization and LTP consolidation.

Ovariectomy thus appears to impair the same signalling cascade used by acute estradiol treatments to produce a mild version of LTP. In accord with these arguments, estradiol infusion quickly restored TBS-induced actin polymerization and the capacity for stable LTP in slices from long-term OVX rats. This is not to say that ovariectomy disrupts plasticity simply by reducing moment-to-moment levels of estradiol available at synapses. Prior studies showed that production of NMDA receptor subunits is disturbed in OVX rats, resulting in an imbalance between the two categories of ionotropic glutamate receptors at synapses (Smith and McMahon, 2005, 2006). There are also a variety of well-established genomic effects associated with ovariectomy that are likely to affect synaptic mechanisms (Spencer et al., 2008). Additional studies can thus be expected to reveal defects in the OVX slice that are not reversed by acute estradiol. Integrating this information with the findings described here will provide a framework for addressing the cognitive issues sometimes reported to accompany surgical ovariectomy (Sherwin, 1988) or menopause (Devi et al., 2005; Wegesin and Stern, 2007).

Acknowledgments

These studies were supported by NINDS grants NS045260 to GL and CMG. CSR was supported by NS045540 and LYC by NIMH fellowship MH083396.

Citations

  • Arai A, Lynch G. Factors regulating the magnitude of long-term potentiation induced by theta pattern stimulation. Brain Res. 1992;598:173–184. [PubMed]
  • Arai A, Silberg J, Lynch G. Differences in the refractory properties of two distinct inhibitory circuitries in field CA1 of the hippocampus. Brain Res. 1995;704:298–306. [PubMed]
  • Bi R, Broutman G, Foy MR, Thompson RF, Baudry M. The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci U S A. 2000;97:3602–3607. [PubMed]
  • Chen LY, Rex CS, Casale MS, Gall CM, Lynch G. Changes in synaptic morphology accompany actin signaling during LTP. J Neurosci. 2007;27:5363–5372. [PubMed]
  • Devi G, Hahn K, Massimi S, Zhivotovskaya E. Prevalence of memory loss complaints and other symptoms associated with the menopause transition: a community survey. Gend Med. 2005;2:255–264. [PubMed]
  • Edwards DC, Sanders LC, Bokoch GM, Gill GN. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol. 1999;1:253–259. [PubMed]
  • Fink G, Sumner BE, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol. 1996;16:325–344. [PubMed]
  • Foy MR, Baudry M, Foy JG, Thompson RF. 17beta-estradiol modifies stress-induced and age-related changes in hippocampal synaptic plasticity. Behav Neurosci. 2008;122:301–309. [PubMed]
  • Foy MR, Xu J, Xie X, Brinton RD, Thompson RF, Berger TW. 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J Neurophysiol. 1999;81:925–929. [PubMed]
  • Fukazawa Y, Saitoh Y, Ozawa F, Ohta Y, Mizuno K, Inokuchi K. Hippocampal LTP is accompanied by enhanced F-actin content within the dendritic spine that is essential for late LTP maintenance in vivo. Neuron. 2003;38:447–460. [PubMed]
  • Giretti MS, Fu XD, De Rosa G, Sarotto I, Baldacci C, Garibaldi S, Mannella P, Biglia N, Sismondi P, Genazzani AR, Simoncini T. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion. PLoS ONE. 2008;3:e2238. [PMC free article] [PubMed]
  • Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci. 1990;10:1286–1291. [PubMed]
  • Gungabissoon RA, Bamburg JR. Regulation of growth cone actin dynamics by ADF/cofilin. J Histochem Cytochem. 2003;51:411–420. [PubMed]
  • Gureviciene I, Puolivali J, Pussinen R, Wang J, Tanila H, Ylinen A. Estrogen treatment alleviates NMDA-antagonist induced hippocampal LTP blockade and cognitive deficits in ovariectomized mice. Neurobiol Learn Mem. 2003;79:72–80. [PubMed]
  • Honkura N, Matsuzaki M, Noguchi J, Ellis-Davies GC, Kasai H. The subspine organization of actin fibers regulates the structure and plasticity of dendritic spines. Neuron. 2008;57:719–729. [PubMed]
  • Kramár EA, Lin B, Rex CS, Gall CM, Lynch G. Integrin-driven actin polymerization consolidates long-term potentiation. Proc Natl Acad Sci U S A. 2006;103:5579–5584. [PubMed]
  • Kramár EA, Lin B, Lin CY, Arai AC, Gall CM, Lynch G. A novel mechanism for the facilitation of theta-induced long-term potentiation by brain-derived neurotrophic factor. J Neurosci. 2004;24:5151–5161. [PubMed]
  • Krucker T, Siggins GR, Halpain S. Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus. Proc Natl Acad Sci U S A. 2000;97:6856–6861. [PubMed]
  • Larson J, Wong D, Lynch G. Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res. 1986;368:347–350. [PubMed]
  • Lee AW, Pfaff DW. Hormone effects on specific and global brain functions. J Physiol Sci. 2008;58:213–220. [PubMed]
  • Lin B, Kramár EA, Bi X, Brucher FA, Gall CM, Lynch G. Theta stimulation polymerizes actin in dendritic spines of hippocampus. J Neurosci. 2005;25:2062–2069. [PubMed]
  • Liu F, Day M, Muniz LC, Bitran D, Arias R, Revilla-Sanchez R, Grauer S, Zhang G, Kelley C, Pulito V, Sung A, Mervis RF, Navarra R, Hirst WD, Reinhart PH, Marquis KL, Moss SJ, Pangalos MN, Brandon NJ. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci. 2008;11:334–343. [PubMed]
  • Luine VN, Jacome LF, Maclusky NJ. Rapid enhancement of visual and place memory by estrogens in rats. Endocrinology. 2003;144:2836–2844. [PubMed]
  • Lynch G, Rex CS, Gall CM. LTP consolidation: substrates, explanatory power, and functional significance. Neuropharmacology. 2007;52:12–23. [PubMed]
  • Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 1999;285:895–898. [PubMed]
  • Markowska AL. Sex dimorphisms in the rate of age-related decline in spatial memory: relevance to alterations in the estrous cycle. J Neurosci. 1999;19:8122–8133. [PubMed]
  • Matsuzaki M, Honkura N, Ellis-Davies GC, Kasai H. Structural basis of long-term potentiation in single dendritic spines. Nature. 2004;429:761–766. [PubMed]
  • Messaoudi E, Kanhema T, Soule J, Tiron A, Dagyte G, da Silva B, Bramham CR. Sustained Arc/Arg3.1 synthesis controls long-term potentiation consolidation through regulation of local actin polymerization in the dentate gyrus in vivo. J Neurosci. 2007;27:10445–10455. [PubMed]
  • Milner TA, Ayoola K, Drake CT, Herrick SP, Tabori NE, McEwen BS, Warrier S, Alves SE. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J Comp Neurol. 2005;491:81–95. [PubMed]
  • Newpher TM, Ehlers MD. Glutamate receptor dynamics in dendritic microdomains. Neuron. 2008;58:472–497. [PMC free article] [PubMed]
  • Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, Mizuno K. Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem. 2000;275:3577–3582. [PubMed]
  • Okamoto K, Nagai T, Miyawaki A, Hayashi Y. Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity. Nat Neurosci. 2004;7:1104–1112. [PubMed]
  • Packard MG, Teather LA. Posttraining estradiol injections enhance memory in ovariectomized rats: cholinergic blockade and synergism. Neurobiol Learn Mem. 1997;68:172–188. [PubMed]
  • Pan Y, Anthony M, Clarkson TB. Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats. Proc Soc Exp Biol Med. 1999;221:118–125. [PubMed]
  • Reid T, Furuyashiki T, Ishizaki T, Watanabe G, Watanabe N, Fujisawa K, Morii N, Madaule P, Narumiya S. Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. J Biol Chem. 1996;271:13556–13560. [PubMed]
  • Rex CS, Kramár EA, Colgin LL, Lin B, Gall CM, Lynch G. Long-term potentiation is impaired in middle-aged rats: regional specificity and reversal by adenosine receptor antagonists. J Neurosci. 2005;25:5956–5966. [PubMed]
  • Rex CS, Lin CY, Kramár EA, Chen LY, Gall CM, Lynch G. Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus. J Neurosci. 2007;27:3017–3029. [PubMed]
  • Rex CS, Chen LY, Sharma A, Liu J, Babayan AH, Gall CM, Lynch G. Different Rho-GTPase signaling pathways initiate sequencial steps in LTP consolidation. J Cell Bio. 2009;186(1):85–97. [PMC free article] [PubMed]
  • Rhodes ME, Frye CA. ERbeta-selective SERMs produce mnemonic-enhancing effects in the inhibitory avoidance and water maze tasks. Neurobiol Learn Mem. 2006;85:183–191. [PubMed]
  • Sah P, Bekkers JM. Apical dendritic location of slow afterhyperpolarization current in hippocampal pyramidal neurons: implications for the integration of long-term potentiation. J Neurosci. 1996;16:4537–4542. [PubMed]
  • Sasaki Y, Suzuki M, Hidaka H. The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway. Pharmacol Ther. 2002;93:225–232. [PubMed]
  • Sharrow KM, Kumar A, Foster TC. Calcineurin as a potential contributor in estradiol regulation of hippocampal synaptic function. Neuroscience. 2002;113:89–97. [PubMed]
  • Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13:345–357. [PubMed]
  • Singh M, Meyer EM, Simpkins JW. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology. 1995;136:2320–2324. [PubMed]
  • Singh M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 1994;644:305–312. [PubMed]
  • Smith CC, McMahon LL. Estrogen-induced increase in the magnitude of long-term potentiation occurs only when the ratio of NMDA transmission to AMPA transmission is increased. J Neurosci. 2005;25:7780–7791. [PubMed]
  • Smith CC, McMahon LL. Estradiol-induced increase in the magnitude of long-term potentiation is prevented by blocking NR2B-containing receptors. J Neurosci. 2006;26:8517–8522. [PubMed]
  • Sohrabji F, Miranda RC, Toran-Allerand CD. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci U S A. 1995;92:11110–11114. [PubMed]
  • Spencer JL, Waters EM, Romeo RD, Wood GE, Milner TA, McEwen BS. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol. 2008;29:219–237. [PMC free article] [PubMed]
  • Thaxton C, Lopera J, Bott M, Baldwin ME, Kalidas P, Fernandez-Valle C. Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding. Mol Cell Neurosci. 2007;34:231–242. [PubMed]
  • Thirone AC, Speight P, Zulys M, Rotstein OD, Szaszi K, Pedersen SF, Kapus A. Hyperosmotic stress induces Rho/Rho kinase/LIM kinase-mediated cofilin phosphorylation in tubular cells: key role in the osmotically triggered F-actin response. Am J Physiol Cell Physiol. 2009;296:C463–475. [PubMed]
  • Warren SG, Humphreys AG, Juraska JM, Greenough WT. LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Res. 1995;703:26–30. [PubMed]
  • Wegesin DJ, Stern Y. Effects of hormone replacement therapy and aging on cognition: evidence for executive dysfunction. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2007;14:301–328. [PubMed]
  • Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol. 1993;336:293–306. [PubMed]
  • Woolley CS, Gould E, Frankfurt M, McEwen BS. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci. 1990;10:4035–4039. [PubMed]
  • Yildirim M, Janssen WG, Tabori NE, Adams MM, Yuen GS, Akama KT, McEwen BS, Milner TA, Morrison JH. Estrogen and aging affect synaptic distribution of phosphorylated LIM kinase (pLIMK) in CA1 region of female rat hippocampus. Neuroscience. 2008;152:360–370. [PMC free article] [PubMed]
  • Zhan Q, Ge Q, Ohira T, Van Dyke T, Badwey JA. p21-activated kinase 2 in neutrophils can be regulated by phosphorylation at multiple sites and by a variety of protein phosphatases. J Immunol. 2003;171:3785–3793. [PubMed]